Ole Graff
Impact in
- Dermatology top 10%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
Papers in ⓘ
-
- Contact Dermatitis and Allergies 5
- Dermatology and Skin Diseases 3
-
- Botulinum Toxin and Related Neurological Disorders 3
- Co-authors
- Joseph F. Fowler (1 shared paper)Per Dahl Christensen (1 shared paper)Jens Brock Johansen (1 shared paper)Erik Simonsen (1 shared paper)Evald Høj Christiansen (1 shared paper)Bjarne Linde Nørgaard (1 shared paper)Kristian Wachtell (1 shared paper)Sarah Kavanagh (3 shared papers)
- Journals
- American Heart Journal (2 papers)Journal of Dermatological Treatment (2 papers)Alzheimer s & Dementia (1 paper)Pain Medicine (1 paper)Journal of Pain (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Ole Graff
16 papers receiving 332 citations
Peers
Comparison fields: 5 of 70
- Dermatology 59
- Immunology and Allergy 31
- Neurology 62
- Cardiology and Cardiovascular Medicine 90
- Anesthesiology and Pain Medicine 19
Countries citing papers authored by Ole Graff
This map shows the geographic impact of Ole Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Graff more than expected).
Fields of papers citing papers by Ole Graff
This network shows the impact of papers produced by Ole Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Graff. The network helps show where Ole Graff may publish in the future.
Co-authors
The 25 scholars most cited alongside Ole Graff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 72 | |
| 2 | 2012 | 52 | |
| 3 | 2012 | 44 | |
| 4 | 2013 | 32 | |
| 5 | A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy. | 2014 | 29 |
| 6 | 2016 | 22 | |
| 7 | 2001 | 21 | |
| 8 | 2008 | 20 | |
| 9 | 2011 | 19 | |
| 10 | 2015 | 12 | |
| 11 | 2013 | 8 | |
| 12 | 2013 | 7 | |
| 13 | 2016 | 5 | |
| 14 | 2015 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 |
About Ole Graff
Ole Graff is a scholar working on Dermatology, Neurology, Epidemiology, Physiology and Surgery, having authored 17 papers that have together received 353 indexed citations. Recurring topics across this work include Contact Dermatitis and Allergies (5 papers), Dermatology and Skin Diseases (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Pain Mechanisms and Treatments (3 papers), Nail Diseases and Treatments (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Dermatology (59 citations), Immunology and Allergy (31 citations), Neurology (62 citations), Cardiology and Cardiovascular Medicine (90 citations) and Anesthesiology and Pain Medicine (19 citations). Ole Graff has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Joseph F. Fowler, Per Dahl Christensen, Jens Brock Johansen, Erik Simonsen, Evald Høj Christiansen, Bjarne Linde Nørgaard, Kristian Wachtell, Sarah Kavanagh, Christopher F. Bell and Kristian Reich. Their work appears in journals such as American Heart Journal, Journal of Dermatological Treatment, Alzheimer s & Dementia, Pain Medicine and Journal of Pain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.